AntineoplasticsDrug resistance and lack of efficacy; grade 3 hepatic disorders: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1931卷 / 1期

关键词：

D O I：

10.1007/s40278-022-26861-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：64 / 64

相关论文

共 50 条

[1] AntineoplasticsDrug resistance and lack of efficacy: case report
Reactions Weekly, 2020, 1807 (1) : 24 - 24
[2] AntineoplasticsDrug resistance and lack of efficacy: case report
Reactions Weekly, 2023, 1953 (1) : 45 - 45
[3] AntineoplasticsDrug resistance and lack of efficacy : case report
Reactions Weekly, 2023, 1953 (1) : 44 - 44
[4] AntineoplasticsDrug resistance and lack of efficacy: case report
Reactions Weekly, 2022, 1902 (1) : 53 - 53
[5] AntineoplasticsDrug resistance and lack of efficacy: case report
Reactions Weekly, 2022, 1917 (1) : 74 - 74
[6] AntineoplasticsDrug resistance, fatigue and lack of efficacy: case report
Reactions Weekly, 2023, 1966 (1) : 49 - 49
[7] AntineoplasticsDrug resistance, lack of efficacy and myositis: case report
Reactions Weekly, 2023, 1944 (1) : 79 - 79
[8] AntineoplasticsDrug misuse and lack of efficacy: case report
Reactions Weekly, 2023, 1981 (1) : 41 - 41
[9] AntineoplasticsDrug resistance and lack of efficacy: 6 case reports
Reactions Weekly, 2022, 1906 (1) : 61 - 61
[10] AntineoplasticsDrug induced lupus and lack of efficacy: case report
Reactions Weekly, 2025, 2047 (1) : 50 - 50

← 1 2 3 4 5 →